Blue Owl Capital Holdings LP
Filing Date
Global Rank
#3,089
/ 8,607
▲ 269
· as of Mar 2026
Top Industry
Biotechnology
72.8%
3Y Alpha vs SPY
-10.7%
Period ended 3 months ago
Filed May 14, 2026 · 58d
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+29.6%
SPY
+75.9%
Annualised alpha
-11.7%
Max drawdown
−46.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
45 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
15.3%
+6.0 pts
Top 5
47.0%
+5.6 pts
Top 10
70.0%
+9.0 pts
HHI
643
Diversified+152
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 75.6% | $278,376,738 |
| Financial Services | 13.9% | $51,326,645 |
| Consumer Cyclical | 4.8% | $17,782,614 |
| Technology | 4.6% | $16,963,835 |
| Real Estate | 0.7% | $2,730,144 |
| Energy | 0.3% | $1,286,804 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | +1,055,416 | 4,416,353 | $30,075,363 | |
| AQST | Aquestive Therapeutics, Inc. | +822,932 | 1,347,932 | $5,593,917 | |
| MPLT | MapLight Therapeutics, Inc. | +678,871 | 1,005,929 | $20,450,536 | |
| EYPT | EyePoint, Inc. | +520,000 | 912,594 | $11,763,336 | |
| LENZ | LENZ Therapeutics, Inc. | +356,722 | 506,722 | $4,636,506 | |
| LRMR | Larimar Therapeutics, Inc. | +296,317 | 7,120,007 | $32,040,031 | |
| CNDT | CONDUENT Inc | +214,173 | 5,036,595 | $6,446,841 | |
| IMA | ImageneBio, Inc. | +135,552 | 959,337 | $4,796,685 | |
| HLLY | Holley Inc. | +90,252 | 4,236,888 | $13,007,246 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +90,000 | 302,638 | $6,340,266 | |
| PIPR | Piper Sandler Companies | +1,821 | 2,428 | $185,863 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | −2,343,891 | 5,089,015 | $13,333,219 | |
| SGMT | Sagimet Biosciences Inc. | −910,000 | 333,877 | $1,744,507 | |
| CMPX | Compass Therapeutics, Inc. | −525,000 | 2,941,525 | $15,560,667 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −510,000 | 1,419,912 | $4,373,328 | |
| CGEM | Cullinan Therapeutics, Inc. | −441,208 | 1,909,764 | $27,137,746 | |
| IMMX | Immix Biopharma, Inc. | −438,688 | 547,552 | $4,988,198 | |
| ORIC | Oric Pharmaceuticals, Inc. | −365,000 | 150,000 | $1,900,500 | |
| CVEO | Civeo Corp | −190,055 | 180,475 | $4,775,368 | |
| KALV | KalVista Pharmaceuticals, Inc. | −145,000 | 215,000 | $4,327,950 | |
| DELL | Dell Technologies Inc. | −39,949 | 13,899 | $2,281,242 | |
| PVLA | Palvella Therapeutics, Inc. | −9,000 | 31,259 | $3,896,434 | |
| AEON | AEON Biopharma, Inc. | −1,042 | 42,353 | $41,717 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 3,161,348 | $56,556,515 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 545,000 | $7,973,350 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 61,455 | $5,344,741 | |
| OVID | Ovid Therapeutics Inc. | 1,904,666 | $4,228,358 | |
| STWD | Starwood Property Trust, Inc. | 158,545 | $2,730,144 | |
| EVMN | Evommune, Inc. | 100,000 | $2,299,000 | |
| WW | Ww International, Inc. | 95,634 | $1,314,011 | |
| ET | Energy Transfer LP | 5,326 | $102,791 | |
| CAI | Caris Life Sciences, Inc. | 4,711 | $84,232 | |
| GOCOQ | GoHealth, Inc. | 40,770 | $61,562 | |
| KPLT | Katapult Holdings, Inc. | 5,421 | $38,272 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCOR | Procore Technologies, Inc. | 94,264 | $6,856,762 | |
| ROIV | Roivant Sciences Ltd. | 263,249 | $5,712,503 | |
| PAYO | Payoneer Global Inc. | 832,810 | $4,680,392 | |
| IMRX | Immuneering Corp | 665,000 | $4,375,700 | |
| CNTA | Centessa Pharmaceuticals plc | 139,450 | $3,487,644 | |
| CMPS | COMPASS Pathways plc | 469,914 | $3,242,406 | |
| NU | Nu Holdings Ltd. | 173,873 | $2,910,634 | |
| MLYS | Mineralys Therapeutics, Inc. | 65,944 | $2,393,107 | |
| JANX | Janux Therapeutics, Inc. | 100,000 | $1,380,000 | |
| CHYM | Chime Financial, Inc. | 39,886 | $1,003,930 | |
| OMDA | Omada Health, Inc. | 15,377 | $242,649 | |
| TTAN | ServiceTitan, Inc. | 2,266 | $241,329 | |
| BLNE | Beeline Holdings, Inc. | 129,529 | $222,789 | |
| ANGX | Angel Studios, Inc. | 10,000 | $46,700 | |
| No positions match the current search. | ||||
45 positions ·
$368,466,780 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 3,161,348 | $56,556,515 | 15.35% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Reduced | 7,120,007 | $32,040,031 | 8.70% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Added | 4,416,353 | $30,075,363 | 8.16% | |
| NCDL |
Nuveen Churchill Direct Lending Corp.
Financial Services
|
Held | 2,143,626 | $27,266,922 | 7.40% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Reduced | 1,909,764 | $27,137,746 | 7.37% | |
| OBDC |
Blue Owl Capital Corp
Financial Services
|
Held | 2,045,070 | $22,618,474 | 6.14% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Added | 1,005,929 | $20,450,536 | 5.55% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 2,941,525 | $15,560,667 | 4.22% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Reduced | 5,089,015 | $13,333,219 | 3.62% | |
| HLLY |
Holley Inc.
Consumer Cyclical
|
Added | 4,236,888 | $13,007,246 | 3.53% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 912,594 | $11,763,336 | 3.19% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 545,000 | $7,973,350 | 2.16% | |
| CNDT |
CONDUENT Inc
Technology
|
Added | 5,036,595 | $6,446,841 | 1.75% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 302,638 | $6,340,266 | 1.72% | |
| AMOD |
Alpha Modus Holdings, Inc.
Technology
|
Held | 394,078 | $5,800,828 | 1.57% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Added | 1,347,932 | $5,593,917 | 1.52% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 61,455 | $5,344,741 | 1.45% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Reduced | 547,552 | $4,988,198 | 1.35% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Added | 959,337 | $4,796,685 | 1.30% | |
| CVEO |
Civeo Corp
Consumer Cyclical
|
Reduced | 180,475 | $4,775,368 | 1.30% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Added | 506,722 | $4,636,506 | 1.26% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,419,912 | $4,373,328 | 1.19% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Reduced | 215,000 | $4,327,950 | 1.17% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
NEW | 1,904,666 | $4,228,358 | 1.15% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Reduced | 31,259 | $3,896,434 | 1.06% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 2,969,199 | $3,741,190 | 1.02% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Held | 733,568 | $2,750,880 | 0.75% | |
| STWD |
Starwood Property Trust, Inc.
Real Estate
|
NEW | 158,545 | $2,730,144 | 0.74% | |
| DAIC |
CID Holdco, Inc.
Technology
|
Held | 557,361 | $2,396,652 | 0.65% | |
| EVMN |
Evommune, Inc.
Healthcare
|
NEW | 100,000 | $2,299,000 | 0.62% | |
| DELL |
Dell Technologies Inc.
Technology
|
Reduced | 13,899 | $2,281,242 | 0.62% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 150,000 | $1,900,500 | 0.52% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
Reduced | 333,877 | $1,744,507 | 0.47% | |
| WW |
Ww International, Inc.
Healthcare
|
NEW | 95,634 | $1,314,011 | 0.36% | |
| EPD |
Enterprise Products Partners L.P.
Energy
|
Held | 31,290 | $1,184,013 | 0.32% | |
| FLD |
Fold Holdings, Inc.
Financial Services
|
Held | 856,632 | $1,130,754 | 0.31% | |
| MRKR |
Marker Therapeutics, Inc.
Healthcare
|
Held | 554,250 | $720,525 | 0.20% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Held | 1,718 | $363,030 | 0.10% | |
| PIPR |
Piper Sandler Companies
Financial Services
|
Added | 2,428 | $185,863 | 0.05% | |
| ET |
Energy Transfer LP
Energy
|
NEW | 5,326 | $102,791 | 0.03% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
NEW | 4,711 | $84,232 | 0.02% | |
| SHFS |
SHF Holdings, Inc.
Financial Services
|
Held | 75,897 | $63,070 | 0.02% | |
| GOCOQ |
GoHealth, Inc.
Financial Services
|
NEW | 40,770 | $61,562 | 0.02% | |
| AEON |
AEON Biopharma, Inc.
Healthcare
|
Reduced | 42,353 | $41,717 | 0.01% | |
| KPLT |
Katapult Holdings, Inc.
Technology
|
NEW | 5,421 | $38,272 | 0.01% |